Ambu A/S (AMBBY) Stock Price, News & Analysis

Company Overview

Ambu A/S is a global medical device company specializing in the development, manufacture and distribution of single‐use endoscopy, anesthesia and patient monitoring solutions. Its core product portfolio includes single‐use bronchoscopes, duodenoscopes and cystoscopes designed to reduce the risk of cross‐contamination and lower total cost of ownership for hospitals and clinics. In addition to endoscopy, Ambu offers a range of products for anesthesia and resuscitation, such as face masks, laryngeal masks and intubation devices, along with diagnostic tools including electrocardiogram (ECG) electrodes and sleep diagnostics equipment.

Founded in 1937 in Denmark, Ambu has evolved from supplying reusable technical medical devices to pioneering disposable technologies that address infection control and workflow efficiency. Over the decades, the company has expanded its global footprint through strategic investments in research and development as well as targeted acquisitions. Ambu’s products are marketed in more than 100 countries across Europe, the Americas and the Asia‐Pacific region, supported by a network of subsidiaries and distribution partners that enable local customer service, training and technical support.

Headquartered in Ballerup, Denmark, Ambu employs a diverse workforce of research scientists, engineers and healthcare specialists dedicated to advancing patient safety and clinical performance. The company’s executive leadership team is led by CEO Peter Buhl Nielsen, under whose direction Ambu has intensified its focus on innovation in single‐use endoscopy and strengthened its competitive position through collaborations with healthcare providers. Ambu continues to invest in cutting‐edge technologies and sustainable manufacturing practices to address evolving healthcare needs and regulatory requirements worldwide.

Key Stats

• Today's Range: $15.25 to $15.25
• 50-Day Range: $14.74 to $16.89
• 52-Week Range: $13.02 to $22.65
• Volume: N/A
• Average Volume: 125 shs
• Market Capitalization: $3.58 billion
• P/E Ratio: 80.27
• Dividend Yield: 0.20%
• Price Target: N/A
• Consensus Rating: Strong Buy

AMBBY Stock Analysis - Frequently Asked Questions

How have AMBBY shares performed this year?

Ambu A/S's stock was trading at $13.02 at the start of the year. Since then, AMBBY stock has increased by 17.1% and is now trading at $15.25.

How were Ambu A/S's earnings last quarter?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) posted its earnings results on Wednesday, May, 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Ambu A/S had a trailing twelve-month return on equity of 6.31% and a net margin of 6.21%.

How do I buy shares of Ambu A/S?

Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/07/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/22/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - HOSPITALS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AMBBY
• Previous Symbol: OTCMKTS:AMBBY
• CIK: N/A
• Web: www.ambu.com
• Phone: (457) 225-2000
• Fax: N/A
• Employees: 5,196
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.19
• Trailing P/E Ratio: 80.27
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $34.17 million
• Net Margins: 6.21%
• Pretax Margin: N/A
• Return on Equity: 6.31%
• Return on Assets: 4.97%

Debt

• Debt-to-Equity Ratio: 0.08
• Current Ratio: 2.88
• Quick Ratio: 1.67

Sales & Book Value

• Annual Sales: $783.76 million
• Price / Sales: 4.57
• Cash Flow: $0.58 per share
• Price / Cash Flow: 26.47
• Book Value: $3.46 per share
• Price / Book: 4.41

Miscellaneous

• Outstanding Shares: 234,970,000
• Free Float: N/A
• Market Cap: $3.58 billion
• Optionable: Not Optionable
• Beta: 0.90